Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient

Documenti analoghi

• Correction to “Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient”
  Pubblicazione: (2025)
• Brief, Family‐Centered, Videoconference‐Based Behavioral Insomnia Program in Elementary School‐Aged Pediatric Cancer Survivors: A Proof‐of‐Concept Study
  di: Eric S. Zhou, et al.
  Pubblicazione: (2025)
• Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation
  di: Aaron E. Fan, et al.
  Pubblicazione: (2025)
• A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors
  di: Kriti Kumar, et al.
  Pubblicazione: (2026)
• Bridging the Gap: Regional Disparities in Access to Pediatric Hematopoietic Stem Cell Transplantation (HSCT) in the Andean Subregion
  di: Julia Palma, et al.
  Pubblicazione: (2026)